We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Argentex Group Plc | LSE:AGFX | London | Ordinary Share | GB00BJLPH056 | ORD �0.0001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-9.10 | -20.22% | 35.90 | 35.90 | 36.00 | 47.40 | 35.00 | 46.20 | 9,882,931 | 16:29:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Security,commodity Exchanges | 41M | 7M | 0.0618 | 5.81 | 40.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/9/2023 08:29 | Post 1217 Great in depth analysis ! | yump | |
13/9/2023 08:24 | Yeah not inspiring | johndoe23 | |
13/9/2023 07:27 | In line H1'23 results today from Argentex - a tech-enabled foreign exchange dealer and international payments provider. All the details here. | brummy_git | |
07/8/2023 15:22 | Platforms get the interest over the weekend. | trident5 | |
07/8/2023 12:45 | Just checked again and it's been paid. Happened before, don't remember which company. All the machinery seems to slow down during holidays plus temporary help let go when markets are quiet. | melton john | |
07/8/2023 12:29 | Mines not showing either. On friday I should have had two - KITW/AGFX and the former is showing but not the latter. I think it may have been a touch late last year. Tbh I don't really track them, I only really look on a monthly basis (unless someone flags it up). FWIW I'm with Halifax, who seem about average for things like these. | dr biotech | |
07/8/2023 11:21 | Hadn't got mine yet when I checked a while ago. | melton john | |
07/8/2023 09:39 | Divi received in IG ISA last week. | flagon | |
07/8/2023 09:37 | have people here received their div due 2 days ago | ali47fish | |
23/7/2023 20:20 | They are an asset manager - may be Strategic Equity Capital or one of their other funds. | topvest | |
19/7/2023 15:04 | is that gresham house adding her - it s just been taken over! | ali47fish | |
16/7/2023 14:28 | Thank you! | jimtech | |
16/7/2023 11:10 | It's in note 9 to the accounts. 5 LLP members were remunerated £4.2m in the 9 months to December. | trident5 | |
16/7/2023 07:59 | I have noticed a couple of posts mentioning Argentex LLP "skimming" profits. but I can't see this in the accounts. Can someone point me to it in the accounts, please? What I do find is this note that Argentex LLP was bought out by the group: From page 118 of the latest accounts: "In June 2019, immediately prior to the Company’s admission to AIM, Argentex Group PLC acquired all equity interests in Argentex LLP. This was effected through the acquisition of equity interests by a newly formed subsidiary, Argentex Capital Limited, and the acquisition of Pacific Foreign Exchange Limited (now Argentex Foreign Exchange Limited). Argentex LLP, Argentex Capital Limited and Argentex Foreign Exchange Limited are 100% owned (either directly or indirectly) subsidiaries of Argentex Group PLC and consolidated into these Financial Statements." | jimtech | |
14/7/2023 13:49 | Thanks trident5 - yes he said that on the video and mentioned it was due to "rebalancing". I should have mentioned that. He did sell after reflecting on the video though which is quite telling. Anyway, just the dividend for me to receive now. I can always re-enter later if I've been overly cautious. | topvest | |
14/7/2023 12:02 | That's odd. Paul Hill's portfolio exposure earlier this year was only 2% AGFX vs 20%+ EQLS. I'd have thought he was more likely to rebalance EQLS than AGFX. | eagle eye | |
14/7/2023 11:49 | He has a video on Stockopedia (yesterday)where he says he sold out of Argentex to rebalance his portfolio. | trident5 | |
14/7/2023 11:13 | I have no idea (nor do I care) if Paul Hill held/sold. If I did I would ask him directly and request he post here. I suggest you do the same. | toffeeman | |
14/7/2023 10:31 | Yes you have had your say so be a good chap and don’t show your spiteful side by trying to deramp to justify your decision. If you feel you can find a company that has consistent growth throughout the years (please let me know of one, just one) then move on to it. | big7ime | |
14/7/2023 09:49 | I see Paul Hill sold out after the interview as well. 2022 £m Q1 9.5 Q2 10.0 Q3 17.4 Q4 13.6 Total 50.5 2023 Q1 12.3 Q2 12.7 H1 25.0 You are forgetting that Q3 last year was anomalous due to the Truss mini-budget. I suspect they could be £5m down on that this year. Time will tell. | topvest | |
14/7/2023 08:22 | Yeah, the market is massive and they’ve been growing as fast as they dare, he seems very confident that the margins will be better too Still very early stage in their growth path so am happy to ride out any short term turbulence, | big7ime | |
14/7/2023 08:15 | Harry Adams says staff numbers have double over the last 2 1/2 years not over the past year, so not such a spike in staff overhead, plus not all new feet under the table. Staff number in November were 137 and they are now 170. H2 last year revenue was £30m, so to do £55m full year, H2 revenue would need to be flat. To do £35m requires 16.7% revenue growth in H2 on last year which isn't unreasonable. Cash position in December was £26.2m, equivalent to 23.1p a share. Recent trading update should have had more detail, especially in the current economic environment. | eagle eye | |
14/7/2023 08:08 | Lmao the size of these posters trades yesterday. Haha what small time pirrocks | shstt1 | |
13/7/2023 23:22 | The flip side of course is any £1 overshoot in revenue would add £1 in net profit. When did you buy in Trident? Your posting history is almost entirely negative here. I continue to hold most of my original holding, though not as big as it was last year. | dr biotech |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions